M Mousseau

2.0k total citations
55 papers, 823 citations indexed

About

M Mousseau is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, M Mousseau has authored 55 papers receiving a total of 823 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 15 papers in Surgery. Recurrent topics in M Mousseau's work include Cancer Treatment and Pharmacology (17 papers), Ovarian cancer diagnosis and treatment (7 papers) and Colorectal Cancer Treatments and Studies (6 papers). M Mousseau is often cited by papers focused on Cancer Treatment and Pharmacology (17 papers), Ovarian cancer diagnosis and treatment (7 papers) and Colorectal Cancer Treatments and Studies (6 papers). M Mousseau collaborates with scholars based in France, Germany and Belgium. M Mousseau's co-authors include Xavier Ronot, Norbert Noury, R Schaerer, G. Virone, Jacques Demongeot, L. Mignot, Éric Pujade-Lauraine, Jean Boutonnât, Jean‐Paul Guastalla and Éric François and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

M Mousseau

53 papers receiving 792 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Mousseau France 16 454 247 183 170 103 55 823
Joerg Schwock Canada 17 290 0.6× 193 0.8× 122 0.7× 404 2.4× 38 0.4× 36 934
Zhenqiu Liu United States 15 195 0.4× 217 0.9× 180 1.0× 347 2.0× 28 0.3× 31 929
Ahrong Kim South Korea 16 369 0.8× 344 1.4× 203 1.1× 169 1.0× 24 0.2× 49 905
Manohar Pradhan Norway 15 356 0.8× 241 1.0× 102 0.6× 252 1.5× 102 1.0× 50 1.1k
Wojciech Kozłowski Poland 15 219 0.5× 185 0.7× 39 0.2× 224 1.3× 33 0.3× 41 673
Fuxing Zhao China 14 542 1.2× 347 1.4× 103 0.6× 251 1.5× 23 0.2× 56 948
Sukjoong Oh South Korea 13 252 0.6× 107 0.4× 164 0.9× 121 0.7× 14 0.1× 52 783
Yanina Sova Israel 11 264 0.6× 160 0.6× 221 1.2× 204 1.2× 64 0.6× 21 711
Nicola Barnard United States 17 450 1.0× 185 0.7× 99 0.5× 481 2.8× 18 0.2× 40 1.1k

Countries citing papers authored by M Mousseau

Since Specialization
Citations

This map shows the geographic impact of M Mousseau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Mousseau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Mousseau more than expected).

Fields of papers citing papers by M Mousseau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Mousseau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Mousseau. The network helps show where M Mousseau may publish in the future.

Co-authorship network of co-authors of M Mousseau

This figure shows the co-authorship network connecting the top 25 collaborators of M Mousseau. A scholar is included among the top collaborators of M Mousseau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Mousseau. M Mousseau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Jacquet, Emmanuelle, et al.. (2016). Long-Term Survivor with Intrathecal and Intravenous Trastuzumab Treatment in Metastatic Breast Cancer. Targeted Oncology. 11(5). 687–691. 16 indexed citations
3.
Joly, Francisca, Dominique Pasquier, C. Hanzen, et al.. (2016). Impact of art therapy (AT) on fatigue and quality of life (QoL) during adjuvant external beam irradiation (EBI) in breast cancer patients (pts): a randomized trial. Annals of Oncology. 27. vi499–vi499. 3 indexed citations
6.
Gauchez, Anne‐Sophie, et al.. (2008). [Early detection of leptomeningeal metastasis in patients with metastatic breast carcinoma: validation of CA 15-3 measurement in cerebrospinal fluid].. PubMed. 65(6). 653–8. 10 indexed citations
7.
Noury, Norbert, et al.. (2006). A Model for the Measurement of Patient Activity in a Hospital Suite. IEEE Transactions on Information Technology in Biomedicine. 10(1). 92–99. 63 indexed citations
8.
Ducreux, Michel, Olivier Bouché, Jean‐Pierre Pignon, et al.. (2006). Randomised Trial Comparing Three Different Schedules of Infusional 5FU and Raltitrexed Alone as First-Line Therapy in Metastatic Colorectal Cancer. Oncology. 70(3). 222–230. 23 indexed citations
9.
Simonet, Michel, et al.. (2006). A breast cancer terminology for lay people. European Journal of Cancer Supplements. 4(2). 179–180. 1 indexed citations
10.
Pasquier, Dominique, et al.. (2005). Cerb-B2 ou Her-2 : marqueur d'intérêt dans la prise en charge du cancer du sein ?. Immuno-analyse & Biologie Spécialisée. 20(2). 92–95. 1 indexed citations
11.
Mornex, F., L. Thomas, Peter Mohr, et al.. (2003). A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma. Melanoma Research. 13(1). 97–103. 104 indexed citations
12.
Mornex, F., L. Thomas, Peter Mohr, et al.. (2003). Essai de phase III randomisé comparant la fotémustine seule ou associée à une irradiation encéphalique dans les métastases cérébrales de mélanome†. Cancer/Radiothérapie. 7(1). 1–8. 20 indexed citations
13.
Mousseau, M, et al.. (2002). Cancer du sein : épidémiologie, bilan d'extension, modalités thérapeutiques. Médecine Nucléaire. 26(1). 7–21. 3 indexed citations
14.
Boutonnât, Jean, Thierry Bonnefoix, M Mousseau, D Seigneurin, & Xavier Ronot. (1998). Coexpression of multidrug resistance involve proteins: a flow cytometric analysis.. PubMed. 18(4C). 2993–9. 5 indexed citations
15.
Vuillez, J.-P., et al.. (1997). [Evaluation of the diagnostic usefulness of CA125 immunoscintigraphy for ovarian carcinoma follow-up after treatment: contribution of this technique in Grenoble University Medical Center].. PubMed. 84(11). 1033–42. 3 indexed citations
16.
Pujade-Lauraine, Éric, Jean‐Paul Guastalla, Nicoletta Colombo, et al.. (1996). Intraperitoneal recombinant interferon gamma in ovarian cancer patients with residual disease at second-look laparotomy.. Journal of Clinical Oncology. 14(2). 343–350. 130 indexed citations
17.
Culine, Stéphane, Jean‐Pierre Droz, R. Delva, et al.. (1995). Rapidly recycled, intensive alternating chemotherapy in heavily pretreated progressive nonseminomatous germ cell tumors a feasibility study. Urologic Oncology Seminars and Original Investigations. 1(3). 109–114. 5 indexed citations
18.
Ménégoz, F, Marc Colonna, C. Exbrayat, et al.. (1995). A recent increase in the incidence of prostatic carcinoma in a French population: Role of ultrasonography and prostatic specific antigen. European Journal of Cancer. 31(1). 55–58. 24 indexed citations
19.
Mousseau, M, et al.. (1993). A study of the expression of four chemoresistance-related genes in human primary and metastatic brain tumours. European Journal of Cancer. 29(5). 753–759. 39 indexed citations
20.
Leborgne, J, et al.. (1978). [Abdominal intercostal hernia. Report of four cases (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 32(2). 138–41. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026